APTIN

Welcome to the Brand page for “APTIN”, which is offered here for Beta-adrenergic receptor blocker for the management and treatment of cardiac arrhythmias, angina pectoris, and other cardiovascular diseases;.

Its status is currently believed to be active. Its class is unavailable. “APTIN” is believed to be currently owned by “ASTRA PHARMACEUTICAL PRODUCTS, INC.”


Owner:
ASTRA PHARMACEUTICAL PRODUCTS, INC.
Owner Details
Description:
BETA-ADRENERGIC RECEPTOR BLOCKER FOR THE MANAGEMENT AND TREATMENT OF CARDIAC ARRHYTHMIAS, ANGINA PECTORIS, AND OTHER CARDIOVASCULAR DISEASES;
Categories: BETA ADRENERGIC RECEPTOR BLOCKER FOR